UPClytics
View all cases

UPC CFI 1708/2025

Nov 24, 2025·EP4226941 +1 more · PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

Case details
Status
Case Closed
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties
Claimants
Representatives
Respondents
Representatives
Division
The Hague LD
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
  • Thomann, WilliamAdmissible2023-09-06
  • SANOFIAdmissible2023-09-06
  • Weickmann & Weickmann PartmbBAdmissible2023-09-07
  • JG Oppositions LimitedAdmissible2023-09-07
  • ModernaTX, Inc.Admissible2025-07-15
  • SANOFIAdmissible2025-07-22
  • Weickmann & Weickmann Patent- und Rechtsanwälte PartmbBAdmissible2025-07-22
  • BioNTech SEAdmissible2025-07-22
  • Arrowhouse GmbHAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Stefan SchillingLockedLocked
Judge Martin SchmidtLockedLocked

At the UPC: Pfizer Group (31 cases)·GlaxoSmithKline Biologicals SA (20 cases)

Related cases

This dispute contains 2 other proceedings

UPC CFI 1707/2025·UPC CFI 621/2025

3 other defendants litigating the same or a related patent

UPC CFI 1526/2025·UPC CFI 2033/2025·UPC CFI 619/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2025

Document titleDatePublic
Receipt2026-09-10Not public
Cover sheet2026-09-10Not public
Application Respondent2026-09-10Not public
Case closed2026-08-10Not public
Order2026-08-10Not public
Order2026-08-10Not public
Receipt2026-07-25Not public
Cover sheet2026-07-25Not public
Application document Claimant2026-07-25Not public
Interim procedure opened2026-07-24Not public